Nanoscope Therapeutics Announces 3 New Appointments to its Scientific and Clinical Advisory Board

/PRNewswire/ -- Nanoscope Therapeutics, Inc., a clinical-stage biotechnology company developing gene therapies for retinal degenerative diseases, today...

Related Keywords

Houston ,Texas ,United States ,Dallas ,America ,Samarendra Mohanty ,Jeff Heier ,Stephen Tsang ,Srinivas Sadda ,Vittorio Porciatti ,Dan Eramian ,Stephen Kaminsky ,David Boyer ,Arshad Khanani ,Charles Wykoff ,Peter Kaiser ,Psulagna Bhattacharya ,Thomas Yorio ,Steven Gray ,Paul Yang ,Nanoscope Co ,Ophthalmology Clinical Research Unit ,Prnewswire Nanoscope Therapeutics Inc ,Ophthalmology For The Blanton Eye Institute ,Nanoscope Therapeutics Inc ,Duke University Medical Center ,Reno School Of Medicine ,Fellowship At Sierra Eye Associates ,University Of Nevada ,Opus Biotech Communications ,Clinical Research ,Research At Retina Consultants Of Texas ,Greater Houston Retina Research Foundation ,Duke Reading Center ,Scientific Advisory Board ,Nanoscope Co Founder ,Managing Partner ,Sierra Eye Associates ,Clinical Associate Professor ,Reno School ,Associate Professor ,Duke Reading ,Retina Consultants ,Clinical Trials Subcommittee ,Deputy Chair ,Blanton Eye Institute ,Houston Methodist ,Sai Chavala ,Michael Singer ,President Samarendra ,Multi Characteristic Opsin ,Inherited Retinal Degenerations ,Nanoscope Therapeutics ,